Journal for ImmunoTherapy of Cancer

Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities
Magdalena Kovacsovics-Bankowski, Lana Chisholm, Jonna Vercellini, Christopher G Tucker, Ryan Montler, Daniel Haley, Philippa Newell, Jun Ma, Paul Tseng, Ronald Wolf, John T Vetto, Chet Hammill, Paul Hansen, Andrew D Weinberg

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 38; DOI: 10.1186/s40425-014-0038-9
The histone deacetylase inhibitor, LBH589, promotes the systemic cytokine and effector responses of adoptively transferred CD8+ T cells
Dominique N Lisiero, Horacio Soto, Richard G Everson, Linda M Liau, Robert M Prins

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 8; DOI: 10.1186/2051-1426-2-8
Letter to the editor
Camilo E Fadul, Jan L Fisher, Thomas H Hampton, Marc S Ernstoff

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 22; DOI: 10.1186/2051-1426-2-22
Response assessment in metastatic melanoma treated with ipilimumab and bevacizumab: CT tumor size and density as markers for response and outcome
Mizuki Nishino, Anita Giobbie-Hurder, Nikhil H Ramaiya, F Stephen Hodi

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 40; DOI: 10.1186/s40425-014-0040-2
Prolonged repeated vaccine immuno-chemotherapy induces long-term clinical responses and survival for advanced metastatic melanoma
Brendon J Coventry, Carrie A Lilly, Peter Hersey, Antonio Michele, Richard J Bright

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 9; DOI: 10.1186/2051-1426-2-9
Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells
Rachel E Beard, Zhili Zheng, Kiran H Lagisetty, William R Burns, Eric Tran, Stephen M Hewitt, Daniel Abate-Daga, Shannon F Rosati, Howard A Fine, Soldano Ferrone, Steven A Rosenberg, Richard A Morgan

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 25; DOI: 10.1186/2051-1426-2-25
Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma
Joshua S Manusow, Leila Khoja, Nataly Pesin, Anthony M Joshua, Efrem D Mandelcorn

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 41; DOI: 10.1186/s40425-014-0041-1
Targeting tumor-necrosis factor receptor pathways for tumor immunotherapy
David A Schaer, Daniel Hirschhorn-Cymerman, Jedd D Wolchok

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 7; DOI: 10.1186/2051-1426-2-7
A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
Hirokazu Matsushita, Yutaka Enomoto, Haruki Kume, Tohru Nakagawa, Hiroshi Fukuhara, Motofumi Suzuki, Tetsuya Fujimura, Yukio Homma, Kazuhiro Kakimi

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 30; DOI: 10.1186/s40425-014-0030-4
CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy
Christopher L Moertel, Junzhe Xia, Rebecca LaRue, Nate N Waldron, Brian M Andersen, Robert M Prins, Hideho Okada, Andrew M Donson, Nicholas K Foreman, Matthew A Hunt, Christopher A Pennell, Michael R Olin

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (1) 46; DOI: 10.1186/s40425-014-0046-9

Main menu

Journal for ImmunoTherapy of Cancer

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Journal for ImmunoTherapy of Cancer

Pages